NeoRX
San Francisco
About NeoRX
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $65.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2006)
- Ticker: nasdaq:NERX
- Website: poniard.com
- Phone: +1 (650)583-3774
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/neorx-2860478 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.